Virtus ETF Advisers LLC Neurocrine Biosciences Inc Transaction History
Virtus ETF Advisers LLC
- $70.5 Million
- Q1 2025
A detailed history of Virtus ETF Advisers LLC transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Virtus ETF Advisers LLC holds 2,584 shares of NBIX stock, worth $327,005. This represents 0.4% of its overall portfolio holdings.
Number of Shares
2,584
Previous 2,758
6.31%
Holding current value
$327,005
Previous $376,000
24.2%
% of portfolio
0.4%
Previous 0.16%
Shares
29 transactions
Others Institutions Holding NBIX
# of Institutions
649Shares Held
97.1MCall Options Held
749KPut Options Held
553K-
Black Rock Inc. New York, NY14.2MShares$1.8 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.94MShares$1.26 Billion0.02% of portfolio
-
Dodge & Cox San Francisco, CA5.53MShares$700 Million0.37% of portfolio
-
State Street Corp Boston, MA4.86MShares$615 Million0.02% of portfolio
-
Jpmorgan Chase & CO New York, NY2.67MShares$338 Million0.02% of portfolio
About NEUROCRINE BIOSCIENCES INC
- Ticker NBIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 95,639,296
- Market Cap $12.1B
- Description
- Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...